Skip to content

Protein, Sarcopenic Obesity, and COPD

Observational Study to Explore the Relationship Between Dietary Protein Intake and the Prevalence of Sarcopenic Obesity in Adult Female With Chronic Obstructive Pulmonary Disease (COPD): A Pilot Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06735573
Acronym
PROSO-COPD
Enrollment
13
Registered
2024-12-16
Start date
2026-01-01
Completion date
2026-08-27
Last updated
2026-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Diseases, Sarcopenic Obesity

Brief summary

Both sarcopenic obesity and chronic obstructive pulmonary diseases (COPD) are common conditions that mainly affect middle-aged and older adults. Previous research has shown that increased dietary intake of total and plant-based protein is associated with a lower risk of sarcopenic obesity, using data from the EPIC Norfolk study. Furthermore, a systematic review and meta-analysis showed that having sarcopenic obesity was associated with significantly impaired lung function outcomes. Other research has shown that increased intake of dietary protein leads to a better treatment outcome for respiratory diseases. The aim of this pilot observational study is to investigate, in more detail, the relationship between the quantity and source of dietary protein intake, the prevalence of sarcopenic obesity, and lung function, in a small cohort of older female participants with COPD. The study will also consider the role of inflammation in relation to sarcopenic obesity and lung function outcomes. This study will help to improve the understanding of the relationship between sarcopenic obesity and lung function outcomes, and how dietary protein intake and inflammation can affect this relationship and each of the outcomes.

Interventions

OTHERthe relationship between the quantity and source of dietary protein intake, and the prevalence of sarcopenic obesity, and lung function outcomes

Primary Objective The primary objective is to measure the relationship between the quantity and source of dietary protein intake, and the prevalence of sarcopenic obesity, and lung function outcomes, in older female participants with clinically diagnosed COPD. Secondary Objectives The secondary objective is to investigate whether the level of inflammation (plasma CRP) is associated with the intake of total, plant-based and animal-based protein, with the prevalence of sarcopenic obesity, and with lung function outcomes.

Sponsors

University of Aberdeen
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
55 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Women. * Clinically diagnosed with COPD. * Aged 55 years or older.

Exclusion criteria

* Male. * Women who are 54 years or younger. * Those who have dementia. * Unable to read or write in English. * Unable to attend the Human Intervention Studies Unit. * Those within one year life expectancy. * Those who have cancer.

Design outcomes

Primary

MeasureTime frameDescription
Association between dietary protein and the prevalence of sarcopenic obesitythrough study completion, an average of 1 yearAssociation between dietary intake of total, plant-based and animal-based protein and the prevalence of sarcopenic obesity.

Secondary

MeasureTime frameDescription
Association between dietary protein and lung functions outcomesthrough study completion, an average of 1 yearAssociation between dietary intake of total, plant-based and animal-based protein and lung functions outcomes (Forced Vital Capacity (FVC), Forced Expiratory Volume in The First Second(FEV1), and The Ratio of Forced Expiratory Volume in The First Second to Forced Vital Capacity (FEV1/FVC ratio)).

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 4, 2026